You're reading the free version. Trader adds the live tape and alerts.
Start tracking
AXSM Exercise Disclosure
Tabuteau Herriot · SEC Form 4 · Filed Jul 1, 2026
Exercise
Calculated transaction value
$245.85K
Tabuteau Herriot Chief Executive Officer
AXSM
Axsome Therapeutics
AXSM
Transaction date
Jul 1, 2026
Public filing date
Jul 1, 2026
Filing lag
Filed same day
AXSM daily price context
Close on/before transaction
$240.66
Jul 1, 2026
First close after public filing
$244.31
Jul 2, 2026
30-day return after filing
-10.77%
Through Jul 31, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 49,666 shares @ $4.95
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-292985
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$12.18M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Axsome Therapeutics, Inc. AXSM Current | Exercise | Jul 1, 2026 | $245.85K |
| Axsome Therapeutics, Inc. AXSM | Sale | Jul 1, 2026 | $11.93M |
| Axsome Therapeutics, Inc. AXSM | Exercise | Jul 1, 2026 | $0 |